Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: Associations with tumor progression, age and human papillomavirus infection

Gynecologic Oncology

Volumn 101, Issue 3, 2006, Pages 411-417

  Joseph, Thomas ^a   Chacko, Priya ^a   Wesley, Remani ^a   Jayaprakash, P G ^a   James, Francis V ^a   Pillai, M Radhakrishna ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

Cervical cancer; Cytochrome P450; Glutathione S transferase; Human papillomavirus

Indexed keywords

CYTOCHROME P450 1A1; DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GROUPS BY AGE; HUMAN; INDIA; LEUKOCYTE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR GROWTH; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

AGE FACTORS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; DISEASE PROGRESSION; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 33646547224     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.10.033     Document Type: Article

References (38)

1. Parkin D.M., Pisani P., and Ferlay J. Estimates of worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80 (1990) 827-841
2. Berumen J., Ordonez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., et al. Asian American variants of human papilloma virus 16 and the risk of cervical cancer: a case-control study. J. Natl. Cancer Inst. 93 (2001) 1325-1330
3. Jayant K., Rao R.S., Nene B.M., et al. Improved stage at diagnosis of cervical cancer with increased awareness in a rural Indian population. Int. J. Cancer 63 (1995) 161-163
4. Suris J.C., and Dexus S. Survival in cervical cancer. Eur. J. Gynecol. Oncol. 19 (1998) 11-13
5. Munoz N. Human papilloma virus and cancer: the epidemiological evidence. J. Clin. Virol. 19 (2000) 1-5
6. Prokopczyk B., Cox J.E., Hoffmann D., and Waggoner S.E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and non smokers. J. Natl. Cancer Inst. 89 (1997) 868-873
7. McCann M.F., Irwin D.E., Walton L.A., Hulka B.S., Morton J.L., and Axelard C.M. Nicotine and cotinine in the cervical mucus of smokers, passive smokers and non-smokers. Cancer Epidemiol. Biomarkers Prev. 1 (1992) 125-129
8. Simons A.M., Philips D.H., and Coleman D.V. Damage to DNA in cervical epithelium related to smoking tobacco. Br. Med. J. 306 (1993) 1444-1448
9. Sobue T. Association of indoor air pollution and life style with lung cancer in Osaka, Japan. Int. J. Epidemiol. 19 (1990) 862-866
10. Pintos J., Franco E.L., Kowalski L.P., Oliveira B.V., and Curado M.P. Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case-control study. Int. J. Epidemiol. 27 (1998) 936-940
11. Velema J.P., Ferrera A., Figueroa M., Bulnes R., Toro L.A., De Barahona O., et al. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras. Int. J. Cancer 97 (2002) 536-541
12. Gonzalez F.J., and Kimura S. Understanding of the role of xenobiotic metabolism in chemical carcinogenesis using gene knock out mice. Mutation Research 477 (2001) 79-87
13. Lang M., and Perkonen O. Metabolism of xenobiotics and chemical carcinogenesis. In: Veneis P., Malats N., Lag M., d' Errieve A., Caporaso N., Cuzick J., and Boffetta P. (Eds). Metabolic Polymorphisms and Susceptibility to Cancer (1999), IARC Sci. Publ., Lyon, France 13-22
14. Sreelekha T.T., Ramdas K., Pandey M., Thomas G., Nalinakumari K.R., and Pillai M.R. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol. 37 (2001) 593-598
15. Au W.W., Oh H.Y., Grady J., Salama S.A., and Heo M.Y. Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk. Environ. Mol. Mutagen. 37 (2001) 215-225
16. d'Errico A., Taioli E., Chen X., and Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1 (1996) 149-173
17. Hiroven A. Polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Environ. Health Perspect 107 Suppl. 1 (1999) 37-47
18. Kim J.W., Lee C.G., Park Y.G., Kim K.S., Kim I.-K., Sohn Y.W., et al. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1 relation to the incidence rate of cervical carcinoma. Cancer 88 (2000) 2082-2091
19. Chen C., and Nirunsuksiri W. Decreased expression of glutathione S-transferase M1 in HPV/16-transfected human cervical keratinocytes in culture. Carcinogenesis 20 (1999) 699-703
20. Nair P., Gangadevi T., Jayaprakash P.G., Nair M.B., Nair M.K., and Pillai M.R. Increased angiogenesis in the uterine cervix associated with human papilloma virus infection. Pathol. Res. Pract. 195 (1999) 163-169
21. Nair P., Nair M.K., Jayaprakash P.G., and Pillai M.R. Decreased programmed cell death in the uterine cervix associated with high risk human papilloma virus infection. Pathol. Oncol. Res. 5 (1999) 95-103
22. Bailey L.R., Roodi N., Verrier C.S., Yee C.J., Dupont W.D., and Parl F.F. Breast cancer and CYP1A1, GSTM1 and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res. 58 (1998) 65-70
23. Tanimoto K., Hayashi S., Yoshiga K., and Ichikawa T. Polymorphisms of CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol. 35 (1999) 191-196
24. Shields P.G., and Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 18 (2000) 2309-2315
25. Miller M.C., Mohrenweiser H.W., and Bell D.A. Genetic variability in susceptibility and response to toxicants. Toxicol. Lett. 120 (2001) 269-280
26. Oude Ophuis M.O., van Leishout E.M., Roelofs H.M., Peters W.H., and Manni J.J. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer 82 (1998) 936-943
27. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464 (2000) 65-76
28. Marchand L.L., Sigfried A., Lum A., Wilkins L.R., and Lau A.F. Association of CYP1A1, GSTM1 and CYP2E1 polymorphisms with lung cancer suggest cell type specifications to tobacco carcinogens. Cancer Res. 58 (1998) 4858-4863
29. Sugawara T., Nomura E., Sagawa T., Sakuragi N., and Fujimoto S. CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int. J. Gynecol. Cancer 13 (2003) 785-790
30. Rojas M., Alexandrov K., Cascorbi I., Brockmoller J., Likhachev A., Pozharisski K., et al. High benzo (a) pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 Msp1/Msp1-GSTM1 0/0 genotypes. Pharmacogenetics 8 (1998) 109-118
31. Whyatt R.M., Bell D.A., Jedrychowski W., Santella R.M., Garte S.J., Cosma G., et al. Polycyclic aromatic hydrocarbon-DNA adduct in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 19 (1998) 1389-1392
32. Goodman M.T., Mc Duffie K., Hernandez B., Berttram C.C., Wilkens L.R., Guo C., et al. CYP1A1, GSTM1 and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol. Oncol. 81 (2001) 263-269
33. Warwick A., Sarhanis P., Redman C., Pemble S., Taylor J.B., Ketterer B., et al. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15 (1994) 2841-2845
34. Sharma A., Sharma J.K., Murthy N.S., and Mitra A.B. Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population. Neoplasma 51 (2004) 12-16
35. Au W.W., Sierra-Torres C.H., and Tyring S.K. Acquired and genetic susceptibility to cervical cancer. Mutat. Res. 544 (2003) 361-364
36. Sierra-Torres C.H., Au W.W., Arrastia C.D., Cajas-Salazar N., Robazetti S.C., Payne D.A., et al. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ. Mol. Mutagen. 41 (2003) 69-76
37. Joseph T., Kusumakumary P., Chacko P., Abraham A., and Pillai M.R. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children. Pediatric Blood Cancer 43 (2004) 560-567
38. Chacko P., Joseph T., Mathew B.S., Rajan B., and Pillai M.R. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat. Res. 581 (2005) 153-163